FSHB -211G>T stratification for follicle-stimulating hormone treatment of male infertility patients: Making the case for a pharmacogenetic approach in genetic functional secondary hypogonadism

Andrology

Volumn 3, Issue 6, 2015, Pages 1050-1053

  Busch, A S ^a   Kliesch, S ^a   Tuttelmann F ^a   Gromoll, J ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

FSHB; Follicle stimulating hormone; Infertility treatment; Male infertility; Single nucleotide polymorphism

Indexed keywords

RECOMBINANT FOLLITROPIN; FERTILITY PROMOTING AGENT; FOLLITROPIN; FOLLITROPIN BETA SUBUNIT;

ARTICLE; COHORT ANALYSIS; FSHB GENE; FSHR GENE; GENE; GENETIC MARKER; HUMAN; HYPOGONADISM; IDIOPATHIC DISEASE; INTRACYTOPLASMIC SPERM INJECTION; MALE; MALE INFERTILITY; PHARMACOGENETICS; PRIORITY JOURNAL; RECEPTOR GENE; SEMEN ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPERMATOGENESIS; TREATMENT RESPONSE; AGONISTS; DRUG EFFECTS; FEMALE; FERTILITY; GENETICS; GENOTYPE; INFERTILITY THERAPY; INFERTILITY, MALE; PATHOPHYSIOLOGY; PHENOTYPE; PREGNANCY; PROCEDURES; TREATMENT OUTCOME;

FEMALE; FERTILITY; FERTILITY AGENTS; FOLLICLE STIMULATING HORMONE; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT; GENOTYPE; HUMANS; INFERTILITY, MALE; MALE; PHARMACOGENETICS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; REPRODUCTIVE TECHNIQUES, ASSISTED; TREATMENT OUTCOME;

EID: 84957427959     PISSN: 20472919     EISSN: 20472927     Source Type: Journal    
DOI: 10.1111/andr.12094     Document Type: Article

References (36)

1. Ahda Y, Gromoll J, Wunsch A, Asatiani K, Zitzmann M, Nieschlag E & Simoni M. (2005) Follicle-stimulating hormone receptor gene haplotype distribution in normozoospermic and azoospermic men. J Androl 26, 494-499.
2. Anawalt BD. (2013) Approach to male infertility and induction of spermatogenesis. J Clin Endocrinol Metab 98, 3532-3542.
3. Attia AM, Abou-Setta AM & Al-Inany HG. (2013) Gonadotrophins for idiopathic male factor subfertility. Cochrane Database Syst Rev 8, CD005071.
4. Benson CA, Kurz TL & Thackray VG. (2013) A human FSHB promoter SNP associated with low FSH levels in men impairs LHX3 binding and basal FSHB transcription. Endocrinology 154(9), 3016-3021.
5. Boulet SL, Mehta A, Kissin DM, Warner L, Kawwass JF & Jamieson DJ. (2015) Trends in use of and reproductive outcomes associated with intracytoplasmic sperm injection. JAMA 313, 255-263.
6. Bouloux PM, Nieschlag E, Burger HG, Skakkebaek NE, Wu FC, Handelsman DJ, Baker GH, Ochsenkuehn R, Syska A, McLachlan RI, Giwercman A, Conway AJ, Turner L, van Kuijk JH & Voortman G. (2003) Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone. J Androl 24, 604-611.
7. Busch A, Gromoll J, Kliesch S, Zitzmann M & Tüttelmann F. (2015) FSHB -211G>T stratification for FSH treatment of male infertility patients: making the case for a pharmacogenetic approach. Exp Clin Endocrinol Diabetes 123, OP1_02.
8. Davies MJ, Moore VM, Willson KJ, Van Essen P, Priest K, Scott H, Haan EA & Chan A. (2012) Reproductive technologies and the risk of birth defects. N Engl J Med 366, 1803-1813.
9. Dwyer AA, Sykiotis GP, Hayes FJ, Boepple PA, Lee H, Loughlin KR, Dym M, Sluss PM, Crowley WF Jr. & Pitteloud N. (2013) Trial of recombinant follicle-stimulating hormone pretreatment for GnRH-induced fertility in patients with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab 98, E1790-E1795.
10. Ferlin A, Vinanzi C, Selice R, Garolla A, Frigo AC & Foresta C. (2011) Toward a pharmacogenetic approach to male infertility: polymorphism of follicle-stimulating hormone beta-subunit promoter. Fertil Steril 96, 1344-1349 e1342.
11. Foresta C, Bettella A, Merico M, Garolla A, Plebani M, Ferlin A & Rossato M. (2000) FSH in the treatment of oligozoospermia. Mol Cell Endocrinol 161, 89-97.
12. Foresta C, Bettella A, Merico M, Garolla A, Ferlin A & Rossato M. (2002) Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility. Fertil Steril 77, 238-244.
13. Foresta C, Bettella A, Garolla A, Ambrosini G & Ferlin A. (2005) Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study. Fertil Steril 84, 654-661.
14. Grigorova M, Punab M, Ausmees K & Laan M. (2008) FSHB promoter polymorphism within evolutionary conserved element is associated with serum FSH level in men. Hum Reprod 23, 2160-2166.
15. Grigorova M, Punab M, Poolamets O, Kelgo P, Ausmees K, Korrovits P, Vihljajev V & Laan M. (2010) Increased prevalence of the -211 T allele of follicle stimulating hormone (FSH) beta subunit promoter polymorphism and lower serum FSH in infertile men. J Clin Endocrinol Metab 95, 100-108.
16. Grigorova M, Punab M, Zilaitiene B, Erenpreiss J, Ausmees K, Matulevicius V, Tsarev I, Jorgensen N & Laan M. (2011) Genetically determined dosage of follicle-stimulating hormone (FSH) affects male reproductive parameters. J Clin Endocrinol Metab 96, E1534-E1541.
17. Grigorova M, Punab M, Punab AM, Poolamets O, Vihljajev V, Zilaitiene B, Erenpreiss J, Matulevicius V & Laan M. (2014) Reproductive physiology in young men is cumulatively affected by FSH-action modulating genetic variants: FSHR -29G/A and c.2039 A/G, FSHB -211G/T. PLoS ONE 9, e94244.
18. Hoogendoorn B, Coleman SL, Guy CA, Smith K, Bowen T, Buckland PR & O'Donovan MC. (2003) Functional analysis of human promoter polymorphisms. Hum Mol Genet 12, 2249-2254.
19. Kamischke A, Behre HM, Bergmann M, Simoni M, Schafer T & Nieschlag E. (1998) Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial. Hum Reprod 13, 596-603.
20. Kläver R & Gromoll J. (2014) Bringing epigenetics into the diagnostics of the andrology laboratory: challenges and perspectives. Asian J Androl 16, 669-674.
21. Kliesch S, Behre HM & Nieschlag E. (1995) Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male. Fertil Steril 63, 1326-1328.
22. Ko EY, Siddiqi K, Brannigan RE & Sabanegh ES Jr. (2012) Empirical medical therapy for idiopathic male infertility: a survey of the American Urological Association. J Urol 187, 973-978.
23. Krausz C. (2011) Male infertility: pathogenesis and clinical diagnosis. Best Pract Res Clin Endocrinol Metab 25, 271-285.
24. Lindgren I, Giwercman A, Axelsson J & Lundberg Giwercman Y. (2012) Association between follicle-stimulating hormone receptor polymorphisms and reproductive parameters in young men from the general population. Pharmacogenet Genomics 22, 667-672.
25. Morreale M, Balon R, Tancer M & Diamond M. (2011) The impact of stress and psychosocial interventions on assisted reproductive technology outcome. J Sex Marital Ther 37, 56-69.
26. Rockliff HE, Lightman SL, Rhidian E, Buchanan H, Gordon U & Vedhara K. (2014) A systematic review of psychosocial factors associated with emotional adjustment in in vitro fertilization patients. Hum Reprod Update 20, 594-613.
27. Santi D, Granata AR & Simoni M. (2015) Follicle-stimulating hormone treatment of male idiopathic infertility improves pregnancy rate: a meta-analysis. Endocrine Connections 4(3), R46-R58.
28. Selice R, Garolla A, Pengo M, Caretta N, Ferlin A & Foresta C. (2011) The response to FSH treatment in oligozoospermic men depends on FSH receptor gene polymorphisms. Int J Androl 34, 306-312.
29. Simoni M, Gromoll J, Hoppner W, Kamischke A, Krafft T, Stahle D & Nieschlag E. (1999a) Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metab 84, 751-755.
30. Simoni M, Weinbauer GF, Gromoll J & Nieschlag E. (1999b) Role of FSH in male gonadal function. Ann Endocrinol (Paris) 60, 102-106.
31. Tüttelmann F, Gromoll J & Kliesch S. (2008) Genetics of male infertility. Urologe A 47, 1561-1562, 1564-1567.
32. Tüttelmann F, Simoni M, Kliesch S, Ledig S, Dworniczak B, Wieacker P & Ropke A. (2011) Copy number variants in patients with severe oligozoospermia and Sertoli-cell-only syndrome. PLoS ONE 6, e19426.
33. Tüttelmann F, Laan M, Grigorova M, Punab M, Sober S & Gromoll J. (2012) Combined effects of the variants FSHB -211G/T and FSHR 2039A>G on male reproductive parameters. J Clin Endocrinol Metab 97(10), 3639-47.
34. WHO (2010) World Health Organisation Laboratory Manual for the Examination and Processing of Human Semen, 5th edn, Geneva.
35. Wunsch A, Ahda Y, Banaz-Yasar F, Sonntag B, Nieschlag E, Simoni M & Gromoll J. (2005) Single-nucleotide polymorphisms in the promoter region influence the expression of the human follicle-stimulating hormone receptor. Fertil Steril 84, 446-453.
36. Yatsenko AN, Georgiadis AP, Ropke A, Berman AJ, Jaffe T, Olszewska M, Westernstroer B, Sanfilippo J, Kurpisz M, Rajkovic A, Yatsenko SA, Kliesch S, Schlatt S & Tüttelmann F. (2015) X-linked TEX11 mutations, meiotic arrest, and azoospermia in infertile men. N Engl J Med 372, 2097-2107.